The Hippo Pathway: Immunity and Cancer

被引:134
|
作者
Taha, Zaid [1 ]
van Rensburg, Helena J. Janse [1 ]
Yang, Xiaolong [1 ]
机构
[1] Queens Univ, Dept Pathol & Mol Med, Kingston, ON K7L 3N6, Canada
关键词
Hippo pathway; cancer; immunology; immunotherapy; inflammation; MST1/2; LATS1/2; YAP; TAZ; PD-L1; REGULATORY T-CELLS; TUMOR-SUPPRESSOR; PROMOTES APOPTOSIS; SIGNALING PATHWAY; MST1; DEFICIENCY; SELF-RENEWAL; KINASE MST1; CYCLE EXIT; YAP; PROLIFERATION;
D O I
10.3390/cancers10040094
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Since its discovery, the Hippo pathway has emerged as a central signaling network in mammalian cells. Canonical signaling through the Hippo pathway core components (MST1/2, LATS1/2, YAP and TAZ) is important for development and tissue homeostasis while aberrant signaling through the Hippo pathway has been implicated in multiple pathologies, including cancer. Recent studies have uncovered new roles for the Hippo pathway in immunology. In this review, we summarize the mechanisms by which Hippo signaling in pathogen-infected or neoplastic cells affects the activities of immune cells that respond to these threats. We further discuss how Hippo signaling functions as part of an immune response. Finally, we review how immune cell-intrinsic Hippo signaling modulates the development/function of leukocytes and propose directions for future work.
引用
收藏
页数:20
相关论文
共 50 条
  • [1] YAP/Hippo Pathway and Cancer Immunity: It Takes Two to Tango
    Matthaios, Dimitrios
    Tolia, Maria
    Mauri, Davide
    Kamposioras, Konstantinos
    Karamouzis, Michalis
    BIOMEDICINES, 2021, 9 (12)
  • [2] Hippo pathway in mammary gland development and breast cancer
    Shi, Peiguo
    Feng, Jing
    Chen, Ceshi
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2015, 47 (01) : 53 - 59
  • [3] Role of the Hippo Pathway in Fibrosis and Cancer
    Kim, Cho-Long
    Choi, Sue-Hee
    Mo, Jung-Soon
    CELLS, 2019, 8 (05)
  • [4] Deregulation and Therapeutic Potential of the Hippo Pathway in Cancer
    Lin, Kimberly C.
    Park, Hyun Woo
    Guan, Kun-Liang
    ANNUAL REVIEW OF CANCER BIOLOGY, VOL 2, 2018, 2 : 59 - 79
  • [5] Targeting the Hippo Pathway for Breast Cancer Therapy
    Wu, Liqing
    Yang, Xiaolong
    CANCERS, 2018, 10 (11)
  • [6] Clinical implications of the Hippo-YAP pathway in multiple cancer contexts
    Kim, Han-Byul
    Myung, Seung-Jae
    BMB REPORTS, 2018, 51 (03) : 119 - 125
  • [7] The Hippo Pathway in Prostate Cancer
    Salem, Omar
    Hansen, Carsten G.
    CELLS, 2019, 8 (04)
  • [8] Drug-Resistant Breast Cancer: Dwelling the Hippo Pathway to Manage the Treatment
    Kaur, Simran
    Najrn, Mohammad Zeeshan
    Khan, Mohammad Aasif
    Akhter, Naseem
    Shingatgeri, Vyas M.
    Sikenis, Mudra
    Sadaf
    Aloliqi, Abdulaziz A.
    BREAST CANCER-TARGETS AND THERAPY, 2021, 13 : 691 - 700
  • [9] HIPPO PATHWAY - BRIEF OVERVIEW OF ITS RELEVANCE IN CANCER
    Zygulska, A. L.
    Krzemieniecki, K.
    Pierzchalski, P.
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2017, 68 (03): : 311 - 335
  • [10] The Hippo signaling pathway in stem cell biology and cancer
    Mo, Jung-Soon
    Park, Hyun Woo
    Guan, Kun-Liang
    EMBO REPORTS, 2014, 15 (06) : 642 - 656